vs

Side-by-side financial comparison of Cryoport, Inc. (CYRX) and ATRenew Inc. (RERE). Click either name above to swap in a different company.

Cryoport, Inc. is the larger business by last-quarter revenue ($45.5M vs $43.2M, roughly 1.1× ATRenew Inc.). ATRenew Inc. runs the higher net margin — 16.9% vs -17.5%, a 34.4% gap on every dollar of revenue.

Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.

ATRenew Inc. operates a leading pre-owned consumer electronics transaction and servicing ecosystem primarily in China. Its core services include end-to-end device recycling, professional quality inspection, certified refurbishment, and resale of smartphones, laptops, tablets and other digital products, serving both individual consumers and enterprise clients across domestic and select Southeast Asian markets.

CYRX vs RERE — Head-to-Head

Bigger by revenue
CYRX
CYRX
1.1× larger
CYRX
$45.5M
$43.2M
RERE
Higher net margin
RERE
RERE
34.4% more per $
RERE
16.9%
-17.5%
CYRX

Income Statement — Q4 FY2025 vs Q1 FY2023

Metric
CYRX
CYRX
RERE
RERE
Revenue
$45.5M
$43.2M
Net Profit
$-8.0M
$7.3M
Gross Margin
47.8%
Operating Margin
-17.0%
Net Margin
-17.5%
16.9%
Revenue YoY
9.6%
Net Profit YoY
57.4%
EPS (diluted)
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CYRX
CYRX
RERE
RERE
Q4 25
$45.5M
Q3 25
$44.2M
Q2 25
$45.5M
Q1 25
$41.0M
Q4 24
$41.5M
Q3 24
$38.3M
Q2 24
$39.7M
Q1 24
$37.3M
Net Profit
CYRX
CYRX
RERE
RERE
Q4 25
$-8.0M
Q3 25
$-6.9M
Q2 25
$105.2M
Q1 25
$-12.0M
Q4 24
$-18.7M
Q3 24
$805.0K
Q2 24
$-78.0M
Q1 24
$-18.9M
Gross Margin
CYRX
CYRX
RERE
RERE
Q4 25
47.8%
Q3 25
48.2%
Q2 25
47.0%
Q1 25
45.4%
Q4 24
47.0%
Q3 24
45.5%
Q2 24
44.5%
Q1 24
40.4%
Operating Margin
CYRX
CYRX
RERE
RERE
Q4 25
-17.0%
Q3 25
-22.5%
Q2 25
-21.2%
Q1 25
-23.1%
Q4 24
-30.7%
Q3 24
-34.9%
Q2 24
-196.5%
Q1 24
-46.9%
Net Margin
CYRX
CYRX
RERE
RERE
Q4 25
-17.5%
Q3 25
-15.7%
Q2 25
231.4%
Q1 25
-29.2%
Q4 24
-45.1%
Q3 24
2.1%
Q2 24
-196.4%
Q1 24
-50.7%
EPS (diluted)
CYRX
CYRX
RERE
RERE
Q4 25
$-0.19
Q3 25
$-0.18
Q2 25
$2.05
Q1 25
$-0.28
Q4 24
$-0.42
Q3 24
$-0.02
Q2 24
$-1.62
Q1 24
$-0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CYRX
CYRX
RERE
RERE
Cash + ST InvestmentsLiquidity on hand
$411.2M
$228.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$502.6M
$557.1M
Total Assets
$765.0M
$722.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CYRX
CYRX
RERE
RERE
Q4 25
$411.2M
Q3 25
$421.3M
Q2 25
$426.0M
Q1 25
$244.0M
Q4 24
$250.6M
Q3 24
$259.4M
Q2 24
$414.9M
Q1 24
$438.2M
Stockholders' Equity
CYRX
CYRX
RERE
RERE
Q4 25
$502.6M
Q3 25
$513.3M
Q2 25
$519.1M
Q1 25
$398.8M
Q4 24
$401.9M
Q3 24
$418.6M
Q2 24
$400.1M
Q1 24
$472.2M
Total Assets
CYRX
CYRX
RERE
RERE
Q4 25
$765.0M
Q3 25
$774.3M
Q2 25
$773.9M
Q1 25
$699.8M
Q4 24
$703.5M
Q3 24
$701.8M
Q2 24
$852.3M
Q1 24
$942.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CYRX
CYRX
RERE
RERE
Operating Cash FlowLast quarter
$919.0K
Free Cash FlowOCF − Capex
$-4.5M
FCF MarginFCF / Revenue
-10.0%
Capex IntensityCapex / Revenue
12.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CYRX
CYRX
RERE
RERE
Q4 25
$919.0K
Q3 25
$2.2M
Q2 25
$-7.3M
Q1 25
$-4.3M
Q4 24
$-5.5M
Q3 24
$447.0K
Q2 24
$-8.0M
Q1 24
$-3.3M
Free Cash Flow
CYRX
CYRX
RERE
RERE
Q4 25
$-4.5M
Q3 25
$-1.3M
Q2 25
$-11.7M
Q1 25
$-7.5M
Q4 24
$-10.7M
Q3 24
$-3.8M
Q2 24
$-11.8M
Q1 24
$-7.3M
FCF Margin
CYRX
CYRX
RERE
RERE
Q4 25
-10.0%
Q3 25
-2.9%
Q2 25
-25.7%
Q1 25
-18.3%
Q4 24
-25.8%
Q3 24
-9.9%
Q2 24
-29.8%
Q1 24
-19.5%
Capex Intensity
CYRX
CYRX
RERE
RERE
Q4 25
12.0%
Q3 25
7.8%
Q2 25
9.6%
Q1 25
7.7%
Q4 24
12.6%
Q3 24
11.1%
Q2 24
9.5%
Q1 24
10.7%
Cash Conversion
CYRX
CYRX
RERE
RERE
Q4 25
Q3 25
Q2 25
-0.07×
Q1 25
Q4 24
Q3 24
0.56×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons